Simyl MCT Dosage in Infants
For nutritional supplementation in infants, Simyl MCT oil should be dosed at approximately 0.7 ml/kg body weight per day, with total lipid intake not exceeding 3 g/kg/day to avoid fat overload syndrome.
Dosing Framework
The evidence base for Simyl MCT specifically comes from clinical practice rather than FDA-approved indications (the drug label 111 refers to SIMBADOL, a veterinary buprenorphine product for cats, not Simyl MCT oil for human infants).
Practical Dosing Guidelines
For term infants and children:
- Start with 0.7 ml/kg/day of MCT oil based on recent clinical experience 2
- This dose has shown efficacy in pediatric populations with acceptable tolerability
- Maximum total lipid intake should not exceed 3 g/kg/day to match lipid oxidation capacity 33
For preterm infants:
- When using MCT/SO (medium-chain triglyceride/soybean oil) emulsions, 1 g/kg/day is necessary to provide adequate essential fatty acids 3
- Total parenteral lipid intake typically limited to 3.0-4.0 g/kg/day 3
- MCT formulations require higher volumes than pure soybean oil to meet essential fatty acid requirements
Critical Safety Considerations
Fat overload syndrome risk:
- The maximal lipid oxidation rate in young infants is approximately 3 g/kg/day 33
- Any lipid exceeding metabolic utilization gets stored in adipose tissue and increases immune impairment risk
- Monitor for signs of fat overload: hypertriglyceridemia, hepatomegaly, coagulopathy
Gastrointestinal side effects:
- Diarrhea, abdominal pain, and nausea are the most common side effects 4
- Lower MCT doses may reduce gastrointestinal complications 2
- Start low and titrate up based on tolerance
Essential fatty acid deficiency:
- MCT oils lack essential fatty acids (linoleic and linolenic acid)
- Preterm infants require minimum 0.25 g/kg/day linoleic acid 3
- Term infants require minimum 0.1 g/kg/day linoleic acid 3
- When using MCT supplementation, ensure adequate essential fatty acid provision from other sources
Clinical Context
In the cardiac surgery study 5, Simyl MCT oil at 7.8 kcal/ml was used for energy fortification in infants, demonstrating feasibility and potential benefits in reducing ICU stay and infection rates, though differences were not statistically significant. The intervention group achieved approximately 40 kcal more daily intake than controls.
Recent evidence 6 shows MCT supplementation is typically reserved for infants with greater clinical complexity (extreme prematurity, bronchopulmonary dysplasia, extrauterine growth restriction), suggesting it should not be used routinely but rather targeted to high-risk populations.
Monitoring Requirements
- Weekly weight gain and growth parameters
- Serum triglyceride levels if using higher doses
- Essential fatty acid status (triene:tetraene ratio) with prolonged use
- Gastrointestinal tolerance (stool frequency, consistency, abdominal distension)